Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences European Biomarkers Summit

Andreas Jenne's Biography



Andreas Jenne, CEO, Kinaxo Biotechnologies

Sorry, There is currently no biography for this presenter.

Andreas Jenne Image

Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies

Wednesday, 18 May 2011 at 14:15

Add to Calendar ▼2011-05-18 14:15:002011-05-18 15:15:00Europe/LondonMode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics TechnologiesEuropean Biomarkers Summit in LondonLondonSELECTBIOenquiries@selectbiosciences.com

Global quantitative phosphoproteomics facilitates detailed mode-of-action analysis of targeted drugs and discovery of regulated protein phosphorylations that can function as response prediction biomarkers for patient stratification.


Add to Calendar ▼2011-05-18 00:00:002011-05-19 00:00:00Europe/LondonEuropean Biomarkers SummitEuropean Biomarkers Summit in LondonLondonSELECTBIOenquiries@selectbiosciences.com